The company's flagship product, the Respicorder, combines key breathing-based tests to provide a comprehensive view of lung function and inflammation. By integrating multiple tests into a single re-configurable device, Arete Medical Technologies reduces costs and improves usability. Their patent-pending innovations enable the Respicorder to deliver room-sized pulmonary function lab capabilities in a handheld device, making remote monitoring more accessible and affordable. Through their digital therapeutic devices, the company aims to enhance personalized, preventative, and precision management of chronic respiratory conditions, ultimately improving patient outcomes and health system efficiency.